{"rows":[{"id":5642,"title":"Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A Receptor","authors":"M. Braden, James J. Chambers, David E. Nichols","journal":"The FASEB Journal","publication_date":"2006-03-01","publication_year":2006,"doi":"10.1096/fasebj.20.4.a247-c","pubmed_id":null,"openalex_id":"https://openalex.org/W100552415","source_url":"https://doi.org/10.1096/fasebj.20.4.a247-c","substance_tags":"psilocin","topic_tags":"Pharmacology,Receptor Pharmacology,Drug Interactions","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:11","last_checked":"2026-08-09 08:26:00","bibtex":null,"source_record_id":"DOI:10.1096/fasebj.20.4.a247-c","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1096/fasebj.20.4.a247-c","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1096/fasebj.20.4.a247-c","source_url":"https://doi.org/10.1096/fasebj.20.4.a247-c","doi":"10.1096/fasebj.20.4.a247-c","pmid":"","publication_date":"2006-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5322,"title":"Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology","authors":"Evan J. Kyzar, Christopher Collins, Jeremy Green, Siddharth Gaikwad, Andrew Roth, Louis Monnig, Mohamed El-Ounsi, Nicholas Capezio, Andrew J. Freeman, Ari Davis, Allan V. Kalueff","journal":"The FASEB Journal","publication_date":"2012-04-01","publication_year":2012,"doi":"10.1096/fasebj.26.1_supplement.1043.3","pubmed_id":null,"openalex_id":"https://openalex.org/W2946624803","source_url":"https://doi.org/10.1096/fasebj.26.1_supplement.1043.3","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-08-09 08:25:54","bibtex":null,"source_record_id":"DOI:10.1096/fasebj.26.1_supplement.1043.3","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1096/fasebj.26.1_supplement.1043.3","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1096/fasebj.26.1_supplement.1043.3","source_url":"https://doi.org/10.1096/fasebj.26.1_supplement.1043.3","doi":"10.1096/fasebj.26.1_supplement.1043.3","pmid":"","publication_date":"2012-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5208,"title":"Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma models","authors":"Thomas W. Flanagan, Melaine N. Sebastian, Charles D. Nichols","journal":"The FASEB Journal","publication_date":"2017-04-01","publication_year":2017,"doi":"10.1096/fasebj.31.1_supplement.820.4","pubmed_id":null,"openalex_id":"https://openalex.org/W2970574043","source_url":"https://doi.org/10.1096/fasebj.31.1_supplement.820.4","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Inflammation,Immune Function","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:02","last_checked":"2026-08-09 08:25:52","bibtex":null,"source_record_id":"DOI:10.1096/fasebj.31.1_supplement.820.4","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1096/fasebj.31.1_supplement.820.4","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1096/fasebj.31.1_supplement.820.4","source_url":"https://doi.org/10.1096/fasebj.31.1_supplement.820.4","doi":"10.1096/fasebj.31.1_supplement.820.4","pmid":"","publication_date":"2017-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4971,"title":"Receptor binding profiles and behavioral effects of psilocybin analogs","authors":"Grant C. Glatfelter, David R. Manke, Andrew R. Chadayne, Michael H. Baumann","journal":"The FASEB Journal","publication_date":"2022-05-01","publication_year":2022,"doi":"10.1096/fasebj.2022.36.s1.r3639","pubmed_id":null,"openalex_id":"https://openalex.org/W4225399213","source_url":"https://doi.org/10.1096/fasebj.2022.36.s1.r3639","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Receptor Pharmacology,Animal Study,In Vitro Study","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:57","last_checked":"2026-08-09 08:25:42","bibtex":null,"source_record_id":"DOI:10.1096/fasebj.2022.36.s1.r3639","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1096/fasebj.2022.36.s1.r3639","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1096/fasebj.2022.36.s1.r3639","source_url":"https://doi.org/10.1096/fasebj.2022.36.s1.r3639","doi":"10.1096/fasebj.2022.36.s1.r3639","pmid":"","publication_date":"2022-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3940,"title":"Psychedelics Improve the Mental Health of Rats","authors":"Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols","journal":"The FASEB Journal","publication_date":"2019-04-01","publication_year":2019,"doi":"10.1096/fasebj.2019.33.1_supplement.666.1","pubmed_id":null,"openalex_id":"https://openalex.org/W3175025894","source_url":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Animal Study","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-08-09 08:25:50","bibtex":null,"source_record_id":"DOI:10.1096/fasebj.2019.33.1_supplement.666.1","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1096/fasebj.2019.33.1_supplement.666.1","source_url":"https://doi.org/10.1096/fasebj.2019.33.1_supplement.666.1","doi":"10.1096/fasebj.2019.33.1_supplement.666.1","pmid":"","publication_date":"2019-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3859,"title":"One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats","authors":"Meghan Hibicke, Charles D. Nichols","journal":"The FASEB Journal","publication_date":"2020-03-31","publication_year":2020,"doi":"10.1096/fasebj.2020.34.s1.02912","pubmed_id":null,"openalex_id":"https://openalex.org/W3016993897","source_url":"https://doi.org/10.1096/fasebj.2020.34.s1.02912","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Receptor Pharmacology,Adolescents","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-07-04 07:00:39","bibtex":null,"source_record_id":"DOI:10.1096/fasebj.2020.34.s1.02912","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1096/fasebj.2020.34.s1.02912","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1096/fasebj.2020.34.s1.02912","source_url":"https://doi.org/10.1096/fasebj.2020.34.s1.02912","doi":"10.1096/fasebj.2020.34.s1.02912","pmid":"","publication_date":"2020-03-31","importer_version":"2.1.3","text_redistributed":false}},{"id":2024,"title":"Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signaling","authors":"Senese Nicolas, Nguyen Thu, Cologna Stephanie, Rasenick Mark","journal":"The FASEB Journal","publication_date":"2021-05-01","publication_year":2021,"doi":"10.1096/fasebj.2021.35.s1.03168","pubmed_id":null,"openalex_id":"https://openalex.org/W3168028697","source_url":"https://doi.org/10.1096/fasebj.2021.35.s1.03168","substance_tags":"psilocybin,psilocin","topic_tags":"Mechanism of Action,Biomarkers,Clinical Trial,Proteomics","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:28:50","bibtex":null,"source_record_id":"DOI:10.1096/fasebj.2021.35.s1.03168","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1096/fasebj.2021.35.s1.03168","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1096/fasebj.2021.35.s1.03168","source_url":"https://doi.org/10.1096/fasebj.2021.35.s1.03168","doi":"10.1096/fasebj.2021.35.s1.03168","pmid":"","publication_date":"2021-05-01","importer_version":"2.1.3","text_redistributed":false}}],"total":7,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"The FASEB Journal","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}